Acute effects of antileukotrienes on sinonasal polyposis and sinusitis

Ear, Nose and Throat Journal

Volumn 79, Issue 1, 2000, Pages 18-25

  Parnes, Steven M ^a   Chuma, Andrew V ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE RECEPTOR BLOCKING AGENT; ZAFIRLUKAST; ZILEUTON;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUCED DISEASE; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; LIVER TOXICITY; MYALGIA; NOSE CONGESTION; NOSE POLYP; PATHOPHYSIOLOGY; POLYPOSIS; SINUSITIS; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0033968891     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556130007900107     Document Type: Article

References (19)

1. Drazen JM, Austen KF. Leukotrienes and airway responses. Am Rev Respir Dis 1987;136:985-98.
2. O'Byrne P. Leukotrienes in the pathogenesis of asthma. Chest 1997; 111(Suppl):27S-34S.
3. Wenzel SE, Westcott JY, Larsen GL. Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: Relationship to the development of late asthmatic responses. J Allergy Clin Immunol 1991;87:540-8.
4. Liu MC, Bleecker ER, Lichtenstein LM, et al. Evidence for elevated levels of histamine, prostaglandin D., and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am Rev Respir Dis 1990;142:126-32.
5. 4 in humans: Effect of indomethacin. Am Rev Respir Dis 1990;141:1441-5.
6. Taylor IK, O'Shaughnessy KM, Fuller RW, Dollery CT. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet 1991;337:690-4.
7. Barnes NC, de Jong B, Miyamoto T. Worldwide clinical experience with the first marketed leukotriene receptor antagonist. Chest 1997;111(Suppl):52S-60S.
8. O'Byrne PM, Israel E, Drazen JM. Antileukotrienes in the treatment of asthma. Ann Intern Med 1997;127:472-80.
9. 4-receptor antagonist. N Engl J Med 1990;323: 1736-9.
10. Fujimura M, Sakamoto S, Kamio Y, Matsuda T. Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma. Respir Med 1993;87:133-8.
11. Tan RA The role of antileukotrienes in asthma management. Curr Opin Pulm Med 1998;4:25-30.
12. Larocca LM, Maggiano N, Capelli A, et al. Immunopathology of nasal polyps: An immunohistochemical approach. Ann Allergy 1989;63:508-12.
13. Stoop AE, van der Heijden HA, Biewenga J, van der Baan S. Clinical aspects and distribution of immunologically active cells in the nasal mucosa of patients with nasal polyps after endoscopic sinus surgery and treatment with topical corticosteroids. Eur Arch Otorhinolaryngol 1992,249:313-7.
14. Ohnishi M, Ruhno J, Bienenstock J, et al. Hematopoietic growth factor production by cultured cells ot human nasal polyp epithelial scrapings: Kinetics, cell source, and relationship to clinical status. J Allergy Clin Immunol 1989;83:1091-100.
15. Klapan I, Culo F, Culig J, et al. Arachadonic acid metabolites and sinonasal polyposis. I. Possible prognostic value. Am J Otolaryngol 1995;16:396-402.
16. Baenkler HW, Schafer D, Hosemann W. Eicosanoids from biopsy of normal and polypous nasal mucosa. Rhinology 1996;34:166-70.
17. Pinto S, Gallo O, Polli G, et al. Cyclooxygenase and lipoxygenase metabolite generation in nasal polyps. Prostaglandins Leukot Essent Fatty Acids 1997;57:533-7.
18. Crocker IC, Zhou CY, Bewtra AK, et al Glucocorticosteroids inhibit leukotriene production. Ann Allergy Asthma Immunol 1997,78:497-505.
19. Crampette L, Mainprice B, Bloom M, et al Inhibition of mediator and cytokine release from dispersed nasal polyp cells by terfenadine. Allergy 1996;51:346-9.